CAS number：1164500-72-4 molecular formula：C24H22N2O5S2
ML 145 是选择性，竞争性的人 GPR35/CXCR8 拮抗剂，IC50/EC50 为 20.1 nM。ML 145 对 GPR35 的选择性比 GPR55 (IC50/EC50=21.7 μM) 高超 1000 倍。 ML 145 对啮齿动物直系同源物的 GPR35 均无明显活性。 Product Describtion: ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. ML 145 has over 1000-fold more selective for GPR35 compared to GPR55 (IC50/EC50=21.7 μM)[1]. ML 145 has no significant activity for GPR35 at either rodent ortholog.
| Chinese alias | 2-羟基-4-[4-(5-(Z))-5-[(E)-2-甲基-3-苯基丙-2-烯叉] -4-氧-2-磺基亚砜-1,3-噻唑烷-3-基]丁酰基氨基]苯甲酸 | ||
| English alias | 2-Hydroxy-4-[4-(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid | ||
| CAS number | 1164500-72-4 | molecular formula | C24H22N2O5S2 |
| molecular weight | 482.57 g/mol | Exact mass | ≥98%(HPLC) |
| PSA | 164.000 Ų | logp | 5.100 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
